2025 Plenary Keynote Programs

Join colleagues from around the world for the Discovery on Target Plenary Keynote Programs. On Wednesday, September 24, our plenary keynote presentations will bridge both halves of the event, it's the only time our whole community of drug discovery professionals assembles together to learn about big-picture perspectives, innovative technologies, and thought-provoking trends from luminaries in the field. On Thursday, September 25, we'll hear the latest insights and developments from VCs in our Plenary Venture Capital Panel. 

WEDNESDAY, SEPTEMBER 24

PLENARY KEYNOTE PRESENTATION
Gregory L Verdine, PhD, Co Founder & President & CEO & CTO, LifeMine Therapeutics

THURSDAY, SEPTEMBER 25

Insights from Venture Capitalists: Trends in Drug Discovery
Panel Moderator: Daniel A. Erlanson, PhD, Chief Innovation Officer, Frontier Medicines Corporation